Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andy Trotti

Showing results (41-50 of 65) with videos related to

Pageof 7
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 25, 2014
Human papillomavirus and overall survival after progression of oropharyngeal squamous cell carcinomaCarole Fakhry, Qiang Zhang, Phuc Felix Nguyen-Tan, et al.
Head & Neck|August 23, 2019
Changing functional status within 6 months posttreatment is prognostic of overall survival in patients with head and neck cancer: NRG Oncology StudyRonald C Eldridge, Stephanie L Pugh, Andy Trotti, et al.
Practical Radiation Oncology|February 8, 2016
Margin reduction from image guided radiation therapy for soft tissue sarcoma: Secondary analysis of Radiation Therapy Oncology Group 0630 resultsX Allen Li, Xiaojian Chen, Qiang Zhang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2009
Early postoperative paclitaxel followed by concurrent paclitaxel and cisplatin with radiation therapy for patients with resected high-risk head and neck squamous cell carcinoma: report of the phase II trial RTOG 0024David I Rosenthal, Jonathan Harris, Arlene A Forastiere, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2015
Reply to B. O'Sullivan et AlCarole Fakhry, Qiang Zhang, Phuc Felix Nguyen-Tan, et al.
The New England Journal of Medicine|December 3, 2003
Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancerArlene A Forastiere, Helmuth Goepfert, Moshe Maor, et al.
Head & Neck|March 8, 2013
Intensity-modulated radiation therapy as primary treatment for oropharyngeal squamous cell carcinomaJames T May, Nikhil Rao, Roberto D Sabater, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 28, 2012
Long-term results of RTOG 91-11: a comparison of three nonsurgical treatment strategies to preserve the larynx in patients with locally advanced larynx cancerArlene A Forastiere, Qiang Zhang, Randal S Weber, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 2014
p16 protein expression and human papillomavirus status as prognostic biomarkers of nonoropharyngeal head and neck squamous cell carcinomaChristine H Chung, Qiang Zhang, Christina S Kong, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 12, 2009
Validation of lysyl oxidase as a prognostic marker for metastasis and survival in head and neck squamous cell carcinoma: Radiation Therapy Oncology Group trial 90-03Quynh-Thu Le, Jonathan Harris, Anthony M Magliocco, et al.
Pageof 7

Showing results (41-50 of 65) with videos related to

Sort By:
Pageof 7
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 25, 2014
Human papillomavirus and overall survival after progression of oropharyngeal squamous cell carcinomaCarole Fakhry, Qiang Zhang, Phuc Felix Nguyen-Tan, et al.
Head & Neck|August 23, 2019
Changing functional status within 6 months posttreatment is prognostic of overall survival in patients with head and neck cancer: NRG Oncology StudyRonald C Eldridge, Stephanie L Pugh, Andy Trotti, et al.
Practical Radiation Oncology|February 8, 2016
Margin reduction from image guided radiation therapy for soft tissue sarcoma: Secondary analysis of Radiation Therapy Oncology Group 0630 resultsX Allen Li, Xiaojian Chen, Qiang Zhang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2009
Early postoperative paclitaxel followed by concurrent paclitaxel and cisplatin with radiation therapy for patients with resected high-risk head and neck squamous cell carcinoma: report of the phase II trial RTOG 0024David I Rosenthal, Jonathan Harris, Arlene A Forastiere, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2015
Reply to B. O'Sullivan et AlCarole Fakhry, Qiang Zhang, Phuc Felix Nguyen-Tan, et al.
The New England Journal of Medicine|December 3, 2003
Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancerArlene A Forastiere, Helmuth Goepfert, Moshe Maor, et al.
Head & Neck|March 8, 2013
Intensity-modulated radiation therapy as primary treatment for oropharyngeal squamous cell carcinomaJames T May, Nikhil Rao, Roberto D Sabater, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 28, 2012
Long-term results of RTOG 91-11: a comparison of three nonsurgical treatment strategies to preserve the larynx in patients with locally advanced larynx cancerArlene A Forastiere, Qiang Zhang, Randal S Weber, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 2014
p16 protein expression and human papillomavirus status as prognostic biomarkers of nonoropharyngeal head and neck squamous cell carcinomaChristine H Chung, Qiang Zhang, Christina S Kong, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 12, 2009
Validation of lysyl oxidase as a prognostic marker for metastasis and survival in head and neck squamous cell carcinoma: Radiation Therapy Oncology Group trial 90-03Quynh-Thu Le, Jonathan Harris, Anthony M Magliocco, et al.
Pageof 7